Amicus Therapeutics
FOLD
FOLD
257 hedge funds and large institutions have $3.13B invested in Amicus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 103 increasing their positions, 77 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.56% less ownership
Funds ownership: 108.96% → 106.4% (-2.6%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
18% less capital invested
Capital invested by funds: $3.79B → $3.13B (-$665M)
Holders
257
Holding in Top 10
5
Calls
$3.52M
Puts
$2.9M
Top Buyers
| 1 | +$22.9M | |
| 2 | +$17.8M | |
| 3 | +$17.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.5M |
| 5 |
BlackRock
New York
|
+$15.1M |
Top Sellers
| 1 | -$46.7M | |
| 2 | -$26.4M | |
| 3 | -$25.6M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$25.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$14.2M |